• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有重排恒定区外显子的嵌合人-鼠IgG抗体表明多个结构域对体内半衰期有影响。

Chimeric human-mouse IgG antibodies with shuffled constant region exons demonstrate that multiple domains contribute to in vivo half-life.

作者信息

Zuckier L S, Chang C J, Scharff M D, Morrison S L

机构信息

Department of Nuclear Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

出版信息

Cancer Res. 1998 Sep 1;58(17):3905-8.

PMID:9731501
Abstract

Structural features that determine the differing rates of immunoglobulin catabolism are of great relevance to the engineering of immunologically active reagents. Sequences in the CH2 and CH3 region of IgG have been shown to regulate the rate of clearance through their interaction with FcRn. In an attempt to probe additional structural features that regulate antibody half-life, we have investigated two families of chimeric antibodies, composed of identical murine heavy and light antidansyl variable regions joined to human kappa light-chains and wild-type or shuffled human IgG heavy-chain constant regions. These antibodies were iodinated, and their clearance was studied in severe combined immunodeficient mice hosts by whole-body radioactivity measurements. Clearances of the wild-type and recombinant antibodies were biphasic. In a panel of immunoglobulins derived from IgG2 and IgG3, as successive domains were varied from gamma2 to gamma3, beta-phase half-life gradually decreased from 337.0 h to 70.6 h. Statistical analysis suggested that the composition of each of the three domains affected half-life, and no single region of the molecule by itself determined the rate of clearance. In the second panel of immunoglobulins derived from IgG1 and IgG4, the construct with the amino terminus portion of the molecule derived from IgG4, joined within the CH2 domain to the COOH terminus portion of IgG1, had a half-life paradoxically greater than either IgG1, or IgG4 (P < 0.012). All four IgG1/IgG4 constructs demonstrated presence of the concentration catabolism phenomenon, which is a unique hallmark of immunoglobulin catabolism. The contribution of all three constant region domains to immunoglobulin half-life may be due to distant conformational effects in addition to direct binding to protective receptors, and emphasizes the importance of distant sequences on the rate of immunoglobulin catabolism. Interesting possibilities regarding mechanisms controlling immunoglobulin metabolism are raised by the hybrid gamma4/gamma1 molecule with a half-life greater than either parental immunoglobulin. Understanding the relationships between the structure of these molecules and their clearance rate will further our ability to produce immunoglobulins with improved pharmacokinetic properties.

摘要

决定免疫球蛋白分解代谢速率差异的结构特征与免疫活性试剂的工程设计密切相关。已表明IgG的CH2和CH3区域中的序列通过与FcRn相互作用来调节清除率。为了探究调节抗体半衰期的其他结构特征,我们研究了两个嵌合抗体家族,它们由相同的鼠抗丹磺酰重链和轻链可变区与人类κ轻链以及野生型或重排的人类IgG重链恒定区连接而成。这些抗体被碘化,并通过全身放射性测量在严重联合免疫缺陷小鼠宿主中研究其清除情况。野生型和重组抗体的清除是双相的。在一组源自IgG2和IgG3的免疫球蛋白中,随着连续结构域从γ2变为γ3,β相半衰期从337.0小时逐渐降至70.6小时。统计分析表明,三个结构域中的每一个的组成都会影响半衰期,并且分子的任何单个区域本身都不能决定清除率。在源自IgG1和IgG4的第二组免疫球蛋白中,分子氨基末端部分源自IgG4且在CH2结构域内与IgG1的羧基末端部分连接的构建体,其半衰期反常地大于IgG1或IgG4(P < 0.012)。所有四种IgG1 / IgG4构建体都表现出浓度分解代谢现象,这是免疫球蛋白分解代谢的独特标志。所有三个恒定区结构域对免疫球蛋白半衰期的贡献可能不仅归因于与保护性受体的直接结合,还归因于远距离的构象效应,并强调了远距离序列对免疫球蛋白分解代谢速率的重要性。半衰期大于任何一种亲本免疫球蛋白的杂交γ4 /γ1分子提出了有关控制免疫球蛋白代谢机制的有趣可能性。了解这些分子的结构与其清除率之间的关系将提高我们生产具有改善药代动力学特性的免疫球蛋白的能力。

相似文献

1
Chimeric human-mouse IgG antibodies with shuffled constant region exons demonstrate that multiple domains contribute to in vivo half-life.具有重排恒定区外显子的嵌合人-鼠IgG抗体表明多个结构域对体内半衰期有影响。
Cancer Res. 1998 Sep 1;58(17):3905-8.
2
Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.去糖基化嵌合小鼠-人IgG的研究。碳水化合物在人IgG恒定区介导的结构和效应功能中的作用。
J Immunol. 1989 Oct 15;143(8):2595-601.
3
Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptors.通过减少抗体-白细胞介素2融合蛋白与Fc受体的相互作用来提高其疗效。
Cancer Res. 1999 May 1;59(9):2159-66.
4
Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.C2相关碳水化合物结构对Ig效应子功能的影响:在中国仓鼠卵巢细胞糖基化突变体中使用嵌合小鼠-人IgG1抗体进行的研究。
J Immunol. 1998 Apr 1;160(7):3393-402.
5
Genetic engineering of bovine Ig. Construction and characterization of hapten-binding bovine/murine chimeric IgE, IgA, IgG1, IgG2, and IgG3 molecules.牛免疫球蛋白的基因工程。半抗原结合牛/鼠嵌合IgE、IgA、IgG1、IgG2和IgG3分子的构建与特性分析。
J Immunol. 1988 May 15;140(10):3654-9.
6
Human immunoglobulin G and immunoglobulin G subclasses: biochemical, genetic, and clinical aspects.人免疫球蛋白G及免疫球蛋白G亚类:生化、遗传及临床方面
Crit Rev Clin Lab Sci. 1989;27(1):27-58. doi: 10.3109/10408368909106589.
7
Molecular analysis of IgM rheumatoid factor binding to chimeric IgG.IgM类风湿因子与嵌合IgG结合的分子分析
J Immunol. 1991 Jan 15;146(2):603-10.
8
Human IgG2 constant region enhances in vivo stability of anti-tenascin antibody 81C6 compared with its murine parent.与鼠源亲本抗体相比,人IgG2恒定区增强了抗腱生蛋白抗体81C6在体内的稳定性。
Clin Cancer Res. 1998 Oct;4(10):2495-502.
9
Enhanced circulating half-life and hematopoietic properties of a human granulocyte colony-stimulating factor/immunoglobulin fusion protein.人粒细胞集落刺激因子/免疫球蛋白融合蛋白的循环半衰期延长及造血特性增强
Exp Hematol. 2004 May;32(5):441-9. doi: 10.1016/j.exphem.2004.01.012.
10
Addition of a mu-tailpiece to IgG results in polymeric antibodies with enhanced effector functions including complement-mediated cytolysis by IgG4.在IgG上添加一个μ尾段会产生具有增强效应功能的多聚体抗体,包括IgG4介导的补体依赖性细胞溶解。
J Immunol. 1995 Mar 1;154(5):2226-36.

引用本文的文献

1
A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions.一种可循环利用的抗转铁蛋白受体 1 单克隆抗体,通过上调靶点和抗体依赖的细胞毒性效应功能,为红细胞白血病提供有效的治疗方法。
MAbs. 2019 Apr;11(3):593-605. doi: 10.1080/19420862.2018.1564510. Epub 2019 Feb 18.
2
Antibody-Drug Conjugates: Pharmacokinetic/Pharmacodynamic Modeling, Preclinical Characterization, Clinical Studies, and Lessons Learned.抗体药物偶联物:药代动力学/药效动力学建模、临床前特征描述、临床研究及经验教训。
Clin Pharmacokinet. 2018 Jun;57(6):687-703. doi: 10.1007/s40262-017-0619-0.
3
The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy.
新生儿Fc受体FcRn作为药物递送和治疗的靶点。
Adv Drug Deliv Rev. 2015 Aug 30;91:109-24. doi: 10.1016/j.addr.2015.02.005. Epub 2015 Feb 19.
4
On the perplexingly low rate of transport of IgG2 across the human placenta.关于IgG2跨人胎盘转运率低得令人困惑的问题。
PLoS One. 2014 Sep 24;9(9):e108319. doi: 10.1371/journal.pone.0108319. eCollection 2014.
5
Anti-CD20-interferon-β fusion protein therapy of murine B-cell lymphomas.抗 CD20-干扰素-β 融合蛋白治疗小鼠 B 细胞淋巴瘤。
J Immunother. 2013 Jun;36(5):305-18. doi: 10.1097/CJI.0b013e3182993eb9.
6
Development of antihuman IgG antibodies and hematologic deficits but not clinical abnormalities in C57BL/6 mice after repeated administration of human intravenous immunoglobulin.在C57BL/6小鼠反复静脉注射人免疫球蛋白后,出现抗人IgG抗体及血液学缺陷,但无临床异常。
Comp Med. 2012 Feb;62(1):31-6.
7
Subcutaneous bioavailability of therapeutic antibodies as a function of FcRn binding affinity in mice.FcRn 结合亲和力对治疗性抗体在小鼠中皮下生物利用度的影响。
MAbs. 2012 Jan-Feb;4(1):101-9. doi: 10.4161/mabs.4.1.18543.
8
Antibody vectors for imaging.抗体载体用于成像。
Semin Nucl Med. 2010 May;40(3):167-81. doi: 10.1053/j.semnuclmed.2009.12.005.
9
Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC.改善用于癌症治疗的抗体的效应功能:增强抗体依赖的细胞介导的细胞毒性(ADCC)和补体依赖的细胞毒性(CDC)。
Drug Des Devel Ther. 2009 Sep 21;3:7-16.
10
Molecularly defined antibody conjugation through a selenocysteine interface.通过硒代半胱氨酸界面进行分子定义的抗体偶联。
Biochemistry. 2009 Dec 22;48(50):12047-57. doi: 10.1021/bi901744t.